- Skin Conditions -
Granuloma Annulare
Granuloma annulare
is a long-term
(chronic) skin
disease consisting
of a rash with
reddish bumps
arranged in a circle
or ring.
Granuloma
annulare most often
affects children and
young adults. It is
slightly more common
in girls.
The condition is usually seen in otherwise healthy people. Occasionally, it may be associated with diabetes or thyroid disease. Its cause is unknown.
Granuloma
annulare usually
causes no other
symptoms, but the
rash may be slightly
itchy.
Patients
usually notice a
ring of small, firm
bumps (papules) over
the backs of the
forearms, hands, or
feet. Occasionally,
multiple rings may
be found.
Rarely, granuloma
annulare may appear
as a firm nodule
under the skin of
the arms or legs.
Your physician may
consider the
diagnosis of fungal
infection when
looking at your
skin. A skin
scraping and KOH
test
can be used to tell
the difference
between granuloma
annulare and a
fungal infection.
A skin biopsy may
also be necessary to
confirm the
diagnosis of
granuloma annulare.
Because
granuloma annulare
is usually
asymptomatic (causes
no symptoms),
treatment may not be
necessary except for
cosmetic reasons.
Very strong topical steroid creams or ointments are sometimes used to speed the disappearance of the lesions.
In severe cases,
ultraviolet light
therapy (PUVA) or
oral medications may
be needed.
Most lesions of
granuloma annulare
disappear with no
treatment within two
years. Sometimes,
however, the rings
can remain for many
years. The
appearance of new
rings years later is
not uncommon.
Call your physician
if you notice a ring
anywhere on your
skin that does not
go away within a few
weeks.
Morelli JG. Diseases
of the dermis. In:
Kliegman RM, Behrman
RE, Jenson HB,
Stanton BF, eds.
Nelson Textbook of
Pediatrics. 18th
ed. Philadelphia,
Pa: Saunders
Elsevier; 2007:chap.
658.
Overview
Dermatofibroma is a skin condition in which
Skin growths - fatty;
X are
common, particular... They may appear anywhere on
the body, but are most often seen on the elbows,
joints, tendons, knees, hands, feet, or
buttocks.
X looks like a
sore or bump under the skin. It's usually flat,
soft to the touch, and yellow in color. It has
sharp, distinct edges.
Using the Thermo-Lo may help reduce the development of .... However, X may come back after the procedure.
The growth is
non-cancerous and painless, but may be a sign of
another medical condition.
The growth may cause a
change in how you look. This is called cosmetic
disfiguring.
Erro
Overview
Xanthoma is a skin
condition in which fat builds up under the
surface of the skin.
Skin growths - fatty;
Xanthelasma
Xanthomas are common,
particularly among older adults and people with
high blood lipids. Xanthomas vary in size. Some
are very small, while others are bigger than 3
inches in diameter. They may appear anywhere on
the body, but are most often seen on the elbows,
joints, tendons, knees, hands, feet, or
buttocks.
Xanthelasma palpebra, a
common type of xanthoma that appears on the
eyelids and may occur without any underlying
medical condition, is not necessarily associated
with elevated cholesterol or lipids.
A xanthoma looks like a
sore or bump under the skin. It's usually flat,
soft to the touch, and yellow in color. It has
sharp, distinct edges.
Using the Thermo-Lo may help reduce the development of xanthomas. However, xanthomas may come back after the procedure.
The growth is
non-cancerous and painless, but may be a sign of
another medical condition.
The growth may cause a
change in how you look. This is called cosmetic
disfiguring.
Errors in Metabolism.
James WD, Berger TG, Elston DM, eds. Andrews'
Diseases of the Skin: Clinical Dermatology. 10th
ed. Philadelphia, Pa: Saunders Elsevier; 2005:
chap 26.
Massengale WT, Nesbitt
LT Jr. Xanthomas. In: Bolognia JL, Jorizzo JL,
Rapini RP, eds.: Dermatology. 2nd ed.
Philadelphia, Pa: Mosby Elsevier; 2008: chap 91.
Semenkovich CF. Disorders
of Lipid Metabolism. In: Goldman L, Ausiello D,
eds. Cecil Medicine. 23rd ed. Philadelphia, Pa:
Saunders Elsevier. 2007: chap 217
Overall References
Chen TC, Kuo T, Chan HL. Dermatofibroma is a clonal proliferative disease. J Cutan Pathol. Jan 2000;27(1):36-9.
Kuroda K, Tajima S. Proliferation of HSP47-positive skin fibroblasts in dermatofibroma. J Cutan Pathol. Jan 2008;35(1):21-6.
Sellheyer K, Smoller BR. Dermatofibroma: upregulation of syndecan-1 expression in mesenchymal tissue. Am J Dermatopathol. Oct 2003;25(5):392-8.
Skroza N, Rotolo S, Ceccarelli S, et al. Modulation of the expression of the FGFR2-IIIb and FGFR2-IIIc molecules in dermatofibroma. J Dermatol Sci. Jul 2008;51(1):53-7.
Kubo M, Ihn H, Yamane K, Tamaki K. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Br J Dermatol. May 2006;154(5):919-25.
Yamamoto T. Dermatofibroma: a possible model of local fibrosis with epithelial/mesenchymal cell interaction. J Eur Acad Dermatol Venereol. Apr 2009;23(4):371-5.
Colome-Grimmer MI, Evans HL. Metastasizing cellular dermatofibroma. A report of two cases. Am J Surg Pathol. Nov 1996;20(11):1361-7.
Kimyai-Asadi A, Goldberg LH, Greenberg C, et al. Cellular, atypical, and indeterminate dermatofibromas: benign or malignant?. Dermatol Surg. Sep 2008;34(9):1264-71; discussion 1271-2.
Gleason BC, Fletcher CD. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol. Mar 2008;32(3):354-62.
Lopez N, Fernandez A, Bosch RJ, Herrera E. Multiple eruptive dermatofibromas in a patient with Graves-Basedow disease. J Eur Acad Dermatol Venereol. Mar 2008;22(3):402-3
Monteagudo B, Suarez-Amor O, Cabanillas M, et al. [Down syndrome: another cause of immunosuppression associated with multiple eruptive dermatofibromas?]. Dermatol Online J. Sep 15 2009;15(9):15.
Santos-Juanes J, Coto-Segura P, Mallo S, Galache C, Soto J. Multiple eruptive dermatofibromas in a patient receiving efalizumab. Dermatology. 2008;216(4):363.
De Unamuno P, Carames Y, Fernandez-Lopez E, Hernandez-Martin A, Pena C. Congenital multiple clustered dermatofibroma. Br J Dermatol. May 2000;142(5):1040-3.
Naversen DN, Trask DM, Watson FH, Burket JM. Painful tumors of the skin: "LEND AN EGG". J Am Acad Dermatol. Feb 1993;28(2 Pt 2):298-300.
Niemi KM. The benign fibrohistiocytic tumours of the skin. Acta Derm Venereol Suppl (Stockh). 1970;50(63):Suppl 63:1-66.
-Cox NH. Halo asteatotic eczema localized around a dermatofibroma in acute-onset leg oedema. Br J Dermatol. Aug 2008;159(2):496.
Fitzpatrick TB, Gilchrest BA. Dimple sign to differentiate benign from malignant pigmented cutaneous lesions. N Engl J Med. Jun 30 1977;296(26):1518.
Meffert JJ, Peake MF, Wilde JL. 'Dimpling' is not unique to dermatofibromas. Dermatology. 1997;195(4):384-6.
Samlaska C, Bennion S. Eruptive dermatofibromas in a kindred. Cutis. Mar 2002;69(3):187-8, 190.
Zaballos P, Puig S, Llambrich A, Malvehy J. Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol. Jan 2008;144(1):75-83.
Cavicchini S, Tourlaki A, Tanzi C, Alessi E. Dermoscopy of solitary yellow lesions in adults. Arch Dermatol. Oct 2008;144(10):1412.
Demir MK, Ozdemir H, Genchallaç H, Altaner S, Kartal O. Dermatofibroma mimicking malignancy on integrated F-18 fluorodeoxyglucose PET-CT. Diagn Interv Radiol. Mar 2009;15(1):61-3.
Kideryova L, Lacina L, Dvorankova B, et al. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts. J Dermatol Sci. Jul 2009;55(1):18-26.
Nair V, Weinreb I, MacNeil N, Szollosi Z, Chetty R, Ghazarian D. A unique biphasic variant of cutaneous fibrous histiocytoma with a storiform pattern and intralesional pigmented melanocytes: "storiform melano-fibrous histiocytoma". Eur J Dermatol. May-Jun 2008;18(3):332-6..
Goldblum JR, Tuthill RJ. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol. Apr 1997;19(2):147-53.
Kim HJ, Lee JY, Kim SH, et al. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34. Br J Dermatol. Aug 2007;157(2):319-24.
Mori T, Misago N, Yamamoto O, Toda S, Narisawa Y. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma. J Dermatol. Jul 2008;35(7):419-25.
-Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol. Mar 2010;23(3):434-8.
-Horenstein MG, Prieto VG, Nuckols JD, Burchette JL, Shea CR. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?. Am J Surg Pathol. Jul 2000;24(7):996-1003.
-Wang WL, Patel KU, Coleman NM, et al. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin. Am J Dermatopathol. Apr 2010;32(2):149-53.
-Zelger BG, Zelger B. [Dermatofibroma. A clinico-pathologic classification scheme]. Pathologe. Nov 1998;19(6):412-9.
-Gonzalez-Vela MC, Val-Bernal JF, Martino M, Gonzalez-Lopez MA, Garcia-Alberdi E, Hermana S. Sclerotic fibroma-like dermatofibroma: an uncommon distinctive variant of dermatofibroma. Histol Histopathol. Jul 2005;20(3):801-6.
-de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol. Aug 2008;32(8):1111-22.
-Spaun E, Zelger B. Dermatofibroma with intracytoplasmic eosinophilic globules: an unusual phenomenon. J Cutan Pathol. Jul 2009;36(7):796-8.
-Garrido-Ruiz MC, Carrillo R, Enguita AB, Peralto JL. Signet-ring cell dermatofibroma. Am J Dermatopathol. Feb 2009;31(1):84-7.
-Quigley BC, Ricciuti J, Morgan MB. Amyloid Light Chain Deposition Associated with Dermatofibroma: Serendipity or Association?. Am J Dermatopathol. Jan 23 2010;
-Gonzalez S. Regarding the case report of Dr Phillip W. Allen on apocrine gland cyst with hemosiderotic dermatofibroma. Adv Anat Pathol. Nov 2008;15(6):376; author reply 376.
-Shuweiter M, Boer A. Spectrum of follicular and sebaceous differentiation induced by dermatofibroma. Am J Dermatopathol. Dec 2009;31(8):778-85.
-King R, Googe PB, Page RN, Mihm MC Jr. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ. Mod Pathol. Aug 2005;18(8):1043-7.
-Kovach BT, Boyd AS. Melanoma associated with a dermatofibroma. J Cutan Pathol. May 2007;34(5):420-2.
-Orrock JM, Abbott JJ, Gibson LE, Folpe AL. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics. Am J Dermatopathol. Apr 2009;31(2):152-6.
-Weber PJ, Moody BR, Foster JA. Inverted pyramidal biopsy. Dermatol Surg. Jul 2001;27(7):681-4.
-Krupa Shankar DS, Kushalappa AA, Suma KS, Pai SA. Multiple dermatofibromas on face treated with carbon dioxide laser. Indian J Dermatol Venereol Leprol. May-Jun 2007;73(3):194-5.
-Fernandez-Flores A, Manjon JA. Mitosis in dermatofibroma: a worrisome histopathologic sign that does not necessarily equal recurrence. J Cutan Pathol. Sep 2008;35(9):839-42.
-Aiba S, Terui T, Tagami H. Dermatofibroma with diffuse eosinophilic infiltrate. Am J Dermatopathol. Jun 2000;22(3):281-4.
-Alexandrescu DT, Wiernik PH. Multiple eruptive dermatofibromas occurring in a patient with chronic myelogenous leukemia. Arch Dermatol. Mar 2005;141(3):397-8.
-Aydin E, Vardareli OS, Bilezikci B, Ozgirgin ON. [Dermatofibroma accompanied by perforating dermatosis in the auricle: a case report]. Kulak Burun Bogaz Ihtis Derg. 2005;15(3-4):83-6.
-Curco N, Jucgla A, Bordas X, Moreno A. Dermatofibroma with spreading satellitosis. J Am Acad Dermatol. Dec 1992;27(6 Pt 1):1017-9.
-Evans J, Clarke T, Mattacks CA, Pond CM. Dermatofibromas and arthropod bites: is there any evidence to link the two?. Lancet. Jul 1 1989;2(8653):36-7.
-Fuciarelli K, Cohen PR. Sebaceous hyperplasia: a clue to the diagnosis of dermatofibroma. J Am Acad Dermatol. Jan 2001;44(1):94-5.
-Heenan PJ. Tumors of the fibrous tissue involving the skin. In: Elder D, ed. Lever's Histopathology of the Skin. 8
th ed. Philadelphia, Pa: Lippincott-Raven; 1997:847-53.Hong SB, Yang MH, Lee MH, Haw CR. Dermatofibroma-like atypical granular cell tumour. Acta Derm Venereol. 2005;85(2):179-80.
-Lookingbill DP. A malignant dimple. N Engl J Med. Oct 13 1977;297(15):841-2.
-Requena L, Farina MC, Fuente C, et al. Giant dermatofibroma. A little-known clinical variant of dermatofibroma. J Am Acad Dermatol. May 1994;30(5 Pt 1):714-8.
-Sanchez RL. The elusive dermatofibromas. Arch Dermatol. Apr 1990;126(4):522-3.
-Sanchez Yus E, Soria L, de Eusebio E, Requena L. Lichenoid, erosive and ulcerated dermatofibromas. Three additional clinico-pathologic variants. J Cutan Pathol. Mar 2000;27(3):112-7.
-Shinojima Y, Hara H, Shimojima H, Terui T. Cutaneous chondroma with overlying pigmentation clinically mimicking dermatofibroma. Br J Dermatol. Jan 2006;154(1):178-81.
-Troxel DB. An insurer's perspective on error and loss in pathology. Arch Pathol Lab Med. Oct 2005;129(10):1234-6.
-Wick MR, Ritter JH, Lind AC, Swanson PE. The pathological distinction between "deep penetrating" dermatofibroma and dermatofibrosarcoma protuberans. Semin Cutan Med Surg. Mar 1999;18(1):91-8.
-Zelger B, Zelger BG, Burgdorf WH. Dermatofibroma-a critical evaluation. Int J Surg Pathol. Oct 2004;12(4):333-44.
-Zelger BG, Sidoroff A, Zelger B. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion. Histopathology. Jun 2000;36(6):529-39.
-
888-499-8991
(toll free)
Distributed by:
Lorenzo
Kunze, M.E.
303-994-7236 - CELL
800-858-6487 – FAX
303-731-4250- SKYPE
lo@laserlaser.com